Biolife plasma services introduces the new fresenius kabi adaptive nomogram across its u.s. network of plasma donation centers

Bannockburn, ill.--(business wire)--biolife plasma services, part of takeda (tse:4502/nyse:tak), today announced that it has begun introducing the new fresenius kabi adaptive nomogram across its u.s. network of plasma donation centers. the new adaptive nomogram is used on the aurora xi plasmapheresis system, which is in more than half of biolife's u.s. plasma donation centers. this new technology will be running in all biolife donation centers using the aurora xi plasmapheresis system by the en.
TAK Ratings Summary
TAK Quant Ranking